Affiliation: The Netherlands Cancer Institute
Country: The Netherlands
- The predictive value of the 70-gene signature for adjuvant chemotherapy in early breast cancerMichael Knauer
Division of Diagnostic Oncology, Netherlands Cancer Institute, Plesmanlaan, Amsterdam, The Netherlands
Breast Cancer Res Treat 120:655-61. 2010..This benefit was not significant in low risk patients, who were at such low risk for recurrence and cancer-related death, that adding CT does not appear to be clinically meaningful...
- Metastatic potential of T1 breast cancer can be predicted by the 70-gene MammaPrint signatureStella Mook
Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
Ann Surg Oncol 17:1406-13. 2010..Therefore, additional prognostic markers are needed to tailor adjuvant systemic treatment for these relatively low-risk patients. The aim of our study was to evaluate the accuracy of the 70-gene MammaPrint signature in T1 breast cancer...